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Spatiotemporal regulation of cerebral cortex development <p>SAGE analysis reveals spatiotemporally regulated transcripts and overlapping sense and antisense transcripts that are important for  mouse cerebral cortex development</p>
Abstract
Background:  Development of the cerebral cortex requires highly specific spatio-temporal
regulation of gene expression. It is proposed that transcriptome profiling of the cerebral cortex at
various developmental time points or regions will reveal candidate genes and associated molecular
pathways involved in cerebral corticogenesis.
Results: Serial analysis of gene expression (SAGE) libraries were constructed from C57BL/6
mouse cerebral cortices of age embryonic day (E) 15.5, E17.5, postnatal day (P) 1.5 and 4 to 6
months. Hierarchical clustering analysis of 561 differentially expressed transcripts showed
regionalized, stage-specific and co-regulated expression profiles. SAGE expression profiles of 70
differentially expressed transcripts were validated using quantitative RT-PCR assays. Ingenuity
pathway analyses of validated differentially expressed transcripts demonstrated that these
transcripts possess distinctive functional properties related to various stages of cerebral
corticogenesis and human neurological disorders. Genomic clustering analysis of the differentially
expressed transcripts identified two highly transcribed genomic loci, Sox4  and  Sox11, during
embryonic cerebral corticogenesis. These loci feature unusual overlapping sense and antisense
transcripts with alternative polyadenylation sites and differential expression. The Sox4 and Sox11
antisense transcripts were highly expressed in the brain compared to other mouse organs and are
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differentially expressed in both the proliferating and differentiating neural stem/progenitor cells and
P19 (embryonal carcinoma) cells.
Conclusions:  We report validated gene expression profiles that have implications for
understanding the associations between differentially expressed transcripts, novel targets and
related disorders pertaining to cerebral corticogenesis. The study reports, for the first time, spatio-
temporally regulated Sox4 and Sox11 antisense transcripts in the brain, neural stem/progenitor cells
and P19 cells, suggesting they have an important role in cerebral corticogenesis and neuronal/glial
cell differentiation.
Background
Complex behavioral tasks, from perception of sensory input
and the control of motor output to cognitive functions such as
learning and memory, are dependent on the precise develop-
ment of innumerable interconnections of neuronal networks
in the cerebral cortex. The development of the cerebral cortex
(also known as cerebral corticogenesis) involves the specific
influence of intrinsic and extrinsic mechanisms, which are
triggered spatio-temporally [1-4]. Between embryonic day 11
(E11) and 18 (E18), the mouse cerebral cortex develops from
a relatively homogenous band of mitotic multipotent progen-
itor cells into a complex laminated structure containing vari-
ous classes of neuronal cells [2,4-6]. Cerebral corticogenesis
involves: proliferation of multipotent progenitors (E11 to
E16.5); migration of postmitotic cells (E11 to E17); cell mor-
phogenesis (E13 to E18); gliogenesis and synaptogenesis (E16
until early postnatal period); and reorganization, elimination
and stabilization of neuronal networks (up to adulthood).
The mouse cerebral cortex develops in the latero-medial and
rostro-caudal axes [7,8]. At E11, the primordial plexiform
layer begins to form in the most lateral part of the neural wall.
Its growth continues in the latero-medial axis to the medial
part of the telencephalon by E13. The primordial plexiform
layer is also expanded in the rostro-caudal axis. The growth in
this axis is always less than the growth in the latero-medial
axis. The first wave of migratory neuronal cells form the cor-
tical plate 2 days later after the development of the primordial
plexiform layer. These events are followed by the develop-
ment of the cortical plate into an organization of six distinct
layers that forms the adult cerebral cortex. Generally, the ros-
tral-most regions of the adult cerebral cortex consist of areas
involved in executive functions and motor coordination,
whilst the caudal-most regions consist of areas involved in
sensory perception such as visual function. Although distinct
functional arealization of the cerebral cortex do not fully
apply to rodents, mounting evidence suggesting that regu-
lated arealization exists has been shown in mice involving
transcription factors such as empty spiracles homolog 2
(Emx2;  Drosophila) [9,10], paired box gene 6 (Pax6) [9],
COUP transcription factor 1 (Coup-tf1) [11], Sp8 transcription
factor (Sp8) [12,13], distal-less homeobox 1/2 (Dlx1/2) and
gastrulation brain homeobox 2 (Gbx2) [14]. The extensive
cyto-architectural and anatomical changes occurring in a spa-
tio-temporal manner during the peak (E15) and at the end
(E17) of embryonic cerebral neurogenesis as well as during
early postnatal (P1) corticogenesis through to adulthood
involves complex underlying molecular regulatory networks.
Complex molecular regulatory elements are important deter-
minants in both spatial and temporal cerebral corticogenesis.
These elements regulate gene expression at the chromatin,
DNA or RNA, and protein levels through chromatin packag-
ing or remodeling, histone acetylation and deacetylation,
chromatin insulation, DNA methylation, post-transcriptional
regulation and post-translational protein modification or
degradation signaling pathways [15-17]. Other processes
involved in such regulation include pre-mRNA processing
and nuclear mRNA retention by nuclear-specific paraspeckle
complexes [18,19], microRNAs (miRNAs) that interfere with
mRNA translation [20-22], and a new class of under-charac-
terized non-coding RNA transcripts known as natural anti-
sense transcripts (NATs) [23,24]. These regulatory networks
play a pivotal role in establishing when, where and how a
multipotent progenitor cell should proliferate, migrate and
settle at a designated position in the cortex. The information
regarding regulatory networks during cerebral corticogene-
sis, however, remains incomplete and does not provide a
comprehensive view of the underlying regulatory elements
throughout this complex event.
In this study, we employed both short and long 3' serial anal-
ysis of gene expression (SAGE) technologies [25,26] to iden-
tify differentially expressed regulatory elements by
comparing transcriptomes of cerebral cortices generated
from four selected developmental stages: E15.5, E17.5, P1.5
and 4 to 6 months old. We also compared rostral to caudal
regions of E15.5 and left to right regions of adult cerebral cor-
tices. We report temporally co-regulated gene clusters, novel
molecular networks and associated pathways, novel candi-
dates in regionalized development and genomic clustering of
SRY-box containing gene 4 (Sox4) and SRY-box containing
gene 11 (Sox11) sense and antisense transcripts. The genomic
clustering analysis led us to the discovery of spatio-temporal
regulation of novel Sox4 and Sox11 antisense transcripts as
well as differential regulation of these transcripts in prolifer-
ating and differentiating neural stem/progenitor cells
(NSPCs) and P19 (embryonal carcinoma) cells.http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.3
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Results
Generation and analysis of SAGE tags
We constructed 10 SAGE libraries from the cerebral cortex of
E15.5, E17.5 and 4- to 6-month-old adult C57BL/6 mice (N =
10; Table 1). The data from two additional SAGE libraries
generated from E15.5 and P1.5 cerebral cortices from Gun-
nersen et al. [27] were also incorporated into our analysis.
These SAGE libraries represent key stages of cerebral cortico-
genesis and are accessible from the Gene Expression Omni-
bus (GEO) website [GEO: GSE15031] [28]. The libraries
contain a total of 531,266 SAGE tags (approximately 44,000
tags per SAGE library), 223,471 of which are unique (non-
redundant) after screening for artifacts and mapping of short
SAGE tags to long SAGE tags (Table 1). The number of unique
tags in each library ranges from approximately 7,200 to
32,000 due to the variation in library size (approximately
13,500 to 70,000). The distribution of tag abundance, how-
ever, is similar in all libraries (Figures S1 and S2 in Additional
data file 1), in which the majority of tags were detected only
once (58 to 76% or approximately 5,500 to approximately
24,000 tags), representing a trend comparable with previ-
ously reported SAGE analyses of mouse neocortices [27,29].
Of all unique tags, only 5,199 (approximately 2.4%) are com-
mon to all developmental stages. The low number of common
unique tags is most probably due to the high abundance of
tags that occur only once.
Analysis of differentially expressed transcripts/tags
To identify differentially expressed tags/transcripts (DETs),
we considered only those 25,165 unique tags with a count >2
across all libraries. Under stringent analyses (Table S1 in
Additional data file 1), we identified a total of 561 DETs in var-
ious comparisons between developmental stages (Table 2;
Figure S3 in Additional data file 1). A full list of DETs with
assigned IDs is provided in Additional data file 2. Greater
numbers of DETs are observed when the interval of two com-
parative developmental stages becomes wider. We find the
largest number of DETs (approximately 59% or 328 DETs) in
the embryonic versus adult stages (E versus Ad) followed by
P1.5 versus Ad (approximately 34% or 192 DETs), E15.5 ver-
sus P1.5 (approximately 6% or 36 DETs) and E15.5 versus
E17.5 (approximately 7% or 38 DETs) comparisons. These
indicate distinctive transcript signatures during cerebral cor-
tex development. Comparisons between rostral and caudal
E15.5 (R versus C), and left and right adult cerebral cortices
(L versus Ri) are described in a different section below.
Approximately 69% of DETs have been assigned to known
genes and 6% to expressed sequence tags (ESTs), while 10%
of DETs have multiple matches (tag matching multiple gene
identifiers) and 8% having ambiguous matches (tag matching
the same gene identifier at multiple chromosome loci).
Approximately 8% of DETs have no matches and it is most
Table 1
SAGE library information
SAGE library* Sex Age Tissue Generated 
sequences
Generated 
SAGE tag 
(library)
Unique tags Unique tags 
(after scaling 
to 100,000 
tags/library)
GEO 
accession 
number
E15_1† U E15.5 Rostral cerebral 
cortex
2,044 43,327 15,664 36,153 GSM375449
E15_2† U E15.5 Caudal cerebral 
cortex
2,925 39,314 19,929 50,692 GSM375450
E15_3†‡ U E15.5 Cerebral cortex 1,920 44,332 15,787 35,611 GSM375451
E17_1† U E17.5 Cerebral cortex 384 13,573 7,214 53,150 GSM375638
E17_2† U E17.5 Cerebral cortex 1,053 47,733 19,508 40,869 GSM375639
P1_1†‡ U P1.5 Cerebral cortex 4,194 42,869 20,465 47,738 GSM375640
Ad_1 M 4 months Left cerebral 
cortex
2,016 50,760 19,032 37,494 GSM375458
Ad_2 M 4 months Left cerebral 
cortex
1,536 52,476 19,157 36,506 GSM375459
Ad_3 F 5-6 months Left cerebral 
cortex
2,688 30,914 15,998 51,750 GSM375460
Ad_4 F 5 months Left cerebral 
cortex
1,728 43,592 17,262 39,599 GSM375461
Ad_5 F 5-6 months Right cerebral 
cortex
2,684 53,292 21,693 40,706 GSM375462
Ad_6 F 6 months Right cerebral 
cortex
3,264 69,084 31,762 45,976 GSM375463
*Each library was constructed by using an independent mouse cerebral cortex. †Short tags were generated from these libraries. ‡These libraries 
were obtained from [27]. F: female; M: male; U: undetermined sex.http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.4
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likely that these DETs belong to transcripts from less defined
regions, such as centromeric and telomeric areas of a chromo-
some or assembly gaps of the mouse genome.
Hierarchical clustering of DETs
To identify co-regulated genes, all 561 DETs were hierarchi-
cally grouped into 12 clusters based on the calculation of the
Euclidean distance of logged normalized counts (Figure 1).
Clusters 1, 5 and 6 consist of embryonic-specific DETs that
exhibit the highest expression during embryonic develop-
ment of the cerebral cortex. DETs in cluster 1 are expressed
throughout all stages of development but exhibit the lowest
expression in the adult cortex. Expression of DETs in cluster
5 ceases prior to birth, whereas DETs in cluster 6 are
expressed up to early postnatal stage. On the other hand, clus-
ters 4, 8 and 10 consist of adult specific DETs, showing very
similar temporal expression profiles, but with different mag-
nitudes (for example, highest expression in cluster 10). Clus-
ters 2 and 7 are termed 'gene-switching' clusters as they show
interesting expression-switching profiles. Cluster 2 shows an
expression switch between P1.5 and adult stages whilst clus-
ter 7 shows an expression switch between embryonic and
adult stages. Clusters 3 and 9 consist of DETs showing region-
(caudal region of E15.5 cerebral cortex) and stage-specific
(P1.5 only) expression. Clusters 11 and 12 were excluded from
subsequent analyses because they contained very few anno-
tated tags. DETs within the same cluster may be co-regulated
and/or involved in similar biological functions during cere-
bral corticogenesis.
We performed a systematic gene ontology functional cluster-
ing using the standardized Gene Ontology term analysis tool
DAVID (Database for Annotation, Visualization and Inte-
grated Discovery) [30] (Additional data file 3). Functional
analysis of these gene clusters reveals that they have distinc-
tive roles during cerebral corticogenesis. Embryonic-specific
gene clusters (1, 5 and 6) are dominated by genes associated
with cellular protein and macromolecule metabolic processes
or biosynthesis, and nervous system and neuron develop-
ment. These results match with the expected functional ontol-
ogies during embryonic cerebral cortex development in which
neuronal migration, differentiation and axonogenesis events
are at their peak. In contrast, adult-specific gene clusters (4,
8 and 10) consist of genes related to biological processes in
the mature cerebral cortex, such as ion homeostasis, synaptic
transmission and regulation of neurotransmitter level. In
addition, these gene clusters are also enriched for ribonucle-
otide/nucleotide binding activity and components of cyto-
plasmic membrane-bound vesicles. These functional
ontologies are in accordance with adult cerebral cortex func-
tion, which features synaptogenesis and nerve impulse trans-
mission at synapses. Gene-switching clusters 2 and 7 are
enriched with gene ontologies that are similar to both the
embryonic- and adult-specific gene clusters. In addition,
these gene clusters are also enriched for microtubule
cytoskeleton organization and biogenesis, nucleotide biosyn-
thesis and regulation of mRNA translation processes.
Quantitative RT-PCR validation of DETs and gene 
clusters
To ascertain the robustness of the SAGE datasets, we selected
136 candidate DETs and two additional genes of interests
(ATPase, Cu++ transporting, alpha polypeptide, Atp7a, and
cullin-associated and neddylation-dissociated 2, Cand2) for
validation after considering both stage-to-stage and hierar-
chical based analyses (Table S2 in Additional data file 1). The
selected DETs are transcription regulators, chromatin modi-
fiers or post-translational regulators, such as ubiquitination
pathway related molecules. Seventeen DETs are ESTs, which
have been identified in brain-related mouse cDNA libraries or
transcriptomes. Independent quantitative RT-PCR (RT-
qPCR) validation was carried out using three biological repli-
Table 2
Summary of tag classification into various categories and comparisons
DETs in various comparisons*
Category Number of 
DETs†
E15.5 R 
versus C
Adult L 
versus Ri
E15.5 versus 
E17.5
E15.5 versus 
P1.5
P1.5 versus 
Ad
E versus Ad Total
Gene 386 (68.8) 25 (56.8) 10 (58.8) 24 (63.2) 16 (44.4) 114 (59.4) 253 (77.1) 442
EST 33 (5.9) 2 (4.5) 2 (11.8) 1 (2.6) 1 (2.8) 9 (4.7) 24 (7.3) 39
Multiple 
matches
55 (9.8) 9 (20.5) 3 (17.6) 5 (13.2) 4 (11.1) 21(10.9) 23 (7.0) 65
Ambiguous 44 (7.8) 4 (9.1) 2 (11.8) 6 (15.8) 4 (11.1) 14 (7.3) 20 (6.1) 50
No match 43 (7.7) 4 (9.1) 0 (0) 2 (5.3) 11 (30.6) 34 (17.7) 8 (2.4) 59
Total 561 44 17 38 36 192 328 655
Tag classification into various categories and comparisons was based on the mouse genome assembly released in July 2007. Values in parentheses 
represent the 'percentage' across a column. *Total number of tags for various comparisons is 655 (rather than 561) due to the same tag being 
statistically significant in more than one comparison. †Differentially expressed tags. Ad: adult stage; C: caudal region; E: embryonic day/stage; L: adult 
left hemisphere; P: postnatal days; R: rostral region; Ri: adult right hemisphere.http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.5
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cates of unpooled cerebral cortex total RNA for each develop-
mental stage. We validated 70 DETs (including 10 ESTs) from
SAGE profiles of comparisons between two developmental
stages (Additional data file 3) after considering various strin-
gent criteria and cutoffs. The RT-qPCR results for all the 70
validated DETs, Atp7a and Cand2 are presented in Tables 3,
4, 5 and 6 (Additional data file 4). To validate the expression
profiles of gene clusters from the hierarchical clustering anal-
ysis, we performed additional RT-qPCR analyses on 65 vali-
dated DETs (based on the analysis of two developmental
stages), Atp7a and Cand2 by including other developmental
stages (Additional data file 5). The analysis validated 62 out
of 65 DETs (Figure 2). Of these, 22 are from embryonic gene
clusters, 26 from adult gene clusters, and 14 from gene-
switching clusters. We assigned Atp7a and Cand2 to clusters
2 and 5, respectively, based on their RT-qPCR expression pro-
files across all the developmental stages. See Tables 3, 4, 5
and 6 for complete list of DETs and their full gene names.
According to the comparison between two developmental
stages, the most abundantly expressed and validated DETs in
the E versus Ad analysis are Camk2a, Egr1 and Plp1 (Table 3).
In the adult cerebral cortex, the expression of these DETs is
more than 100-fold greater than that at E15.5. Other vali-
dated adult-specific DETs with expression levels of approxi-
mately tenfold or greater than those in the embryonic brain
are Camk2n1, Cryab, Nrgn, BQ176089, CD802535, Sncb and
Nptxr. Conversely, Sox11, an embryonic specific DET, is
expressed in the E15.5 and E17.5 cerebral cortices with an
expression level of at least 100-fold greater than that in the
adult. Other validated embryonic specific DETs are Dcx,
Zfp57, Ezh2, Sfrp1 and Cdk4, which have expression levels
approximately tenfold or greater than those in the adult.
In the P1.5 versus Ad analysis, Dcx is expressed at a level
approximately 80-fold greater in P1.5 compared to the adult
cerebral cortex (Table 4). Other P1.5 enriched and validated
Hierarchical clustering of 561 differentially expressed transcripts/tags Figure 1
Hierarchical clustering of 561 differentially expressed transcripts/tags. Log2 of normalized counts of DETs from cerebral cortices of various 
developmental stages were clustered. Dark green clusters denote high levels of expression whereas light green to white clusters denote low levels of 
expression. The x-axis represents the SAGE libraries whereas the y-axis represents the SAGE tags. The panel on the right shows the 12 different clusters.http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.6
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High-throughput RT-qPCR validation of gene clusters Figure 2
High-throughput RT-qPCR validation of gene clusters. All validations were based on DETs for canonical mRNA. Failed validation of DETs 
according to hierarchical clustering expression profiles is indicated by arrows. N = 3 and data are presented as mean ± standard error of the mean.http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.7
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Table 3
RT-qPCR validation of SAGE profile for E versus adult comparison
Fold change
SAGE tag RefSeq 
accession
Gene ID Ad/E15.5 
(SAGE)
Ad/E17.5 
(SAGE)
Ad/E15.5 
(RT-qPCR)
Ad/E17.5 
(RT-qPCR)
gcttccccacccccctt NM_177407 calcium/calmodulin-
dependent protein 
kinase II alpha, Camk2a
As As 111.59 54.74
ggatatgtggtgtgtac NM_007913 early growth response 
1, Egr1
As As 108.47 38.93
aaattattgggaaatcc NM_011123 proteolipid protein 
(myelin) 1, Plp1
28.77 As 103.15 89.13
gtatttgcaaaaaaaaa NM_025451 calcium/calmodulin-
dependent protein 
kinase II inhibitor 1, 
Camk2n1
69.59 59.76 40.08 21.46
gcttcatctccagggag NM_009964 crystallin, alpha B, 
Cryab
As 11.59 30.47 20.58
ttaccatactgggttgg NM_022029 neurogranin, Nrgn 24.67 8.47 43.67 17.00
cctcatttcccctgttc BQ176089 EST from adult C57BL/
6 subfornical organ and 
postrema tissues
As As 23.01 8.91
acccggctagtagtgaa NM_011129 septin 4, Sept4 18.97 16.29 22.38 12.96
ctcattataatcaagaa CD802535 EST from 27-32 days 
C57BL/6 hippocampus 
tissue
As 9.05 22.03 13.25
aataaagccaatctgac NM_033610 synuclein, beta, Sncb 20.89 7.66 18.20 15.83
gcttttgttaccatctc NM_030689 neuronal pentraxin 
receptor, Nptxr
17.88 12.24 15.02 10.93
tccctcccttagtatcc NM_144828 protein phosphatase 1, 
regulatory (inhibitor) 
subunit 1B, Ppp1r1b
As As 10.47 6.88
gccccttcttcattggc NM_010358 glutathione S-
transferase, mu 1, 
Gstm1
As As 9.87 5.58
tgactagcgtgacctgt NM_007694 chromogranin B, Chgb 6.13 6.30 9.43 7.22
atttcttttctggatgg NM_010585 inositol 1,4,5-
triphosphate receptor 
1, Itpr1
14.34 6.16 9.29 6.12
actttgagattgtacct NM_009062 regulator of G-protein 
signaling 4, Rgs4
12.23 21.01 8.84 5.32
aataattagccttaggt AK139402 Mus musculus 10 days 
neonate cortex cDNA
As As 8.28 7.55
ctagacagaggcattat NM_019634 tetraspanin 7, Tspan7 13.08 5.61 7.99 5.38
tgtatacacacacgggt NM_007547 signal-regulatory 
protein alpha, Sirpa
As As 7.18 4.63
tgacaagacactgtggc AU258168 EST from mouse brain As As 6.49 4.58
cttacctcaggtttcct NM_008913 protein phosphatase 3, 
catalytic subunit, alpha 
isoform, Ppp3ca
As 5.43 5.48 3.45
atagctttctacacact NM_007471 amyloid beta (A4) 
precursor protein, App
3.98 2.74 4.56 3.49
tttcagcagtgttggct NM_013556 hypoxanthine guanine 
phosphoribosyl 
transferase 1, Hprt1
6.90 8.87 3.45 2.85
aggtatgtacaaagttt NM_016886 glutamate receptor, 
ionotropic, AMPA3 
(alpha 3), Gria3
4.97 8.51 3.40 1.81*
tccaacttgtaactata NM_009790 calmodulin 1, Calm1 4.23 3.17 3.24 2.27http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.8
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cctcagcctggggtaga NM_009983 cathepsin D, Ctsd 3.46 2.04 3.22 3.84
gcttcgtccacacagcg NM_010777 myelin basic protein, 
Mbp
202.46 173.85 3.19 2.05
tattaaatgtgcttttt NM_080555 phosphatidic acid 
phosphatase type 2B, 
Ppap2b
5.71 2.44 3.02 2.76
cttatcctcacctcagc NC_005089 NADH dehydrogenase 
6, mitochondrial, mt-
ND6
As As 2.65 2.13
caaacctccaaaaacca AK140219 Mus musculus adult 
male corpora 
quadrigemina cDNA
29.22 18.62 2.63 2.03
agtggctaattaggtgt NM_009900 chloride channel 2, 
Clcn2
14.55 4.16 2.23 2.18
accaatgaacaaaaaaa AK154943 Mus musculus NOD-
derived CD11c +ve 
dendritic cells cDNA
109.40 51.13 1.76* 1.35 (NS)
ccagtacctgaaaaaaa NM_008453 Kruppel-like factor 3 
(basic), Klf3
As -52.97 -1.47†‡ -1.27 (NS)
aagaaaacatttaaata NM_012010 eukaryotic translation 
initiation factor 2, 
subunit 3, structural 
gene X-linked, Eif2s3x
-7.70 -10.38 -1.72* -1.74*
caccctgtgggagctca NM_172656 amyotrophic lateral 
sclerosis 2 (juvenile) 
chromosome region, 
candidate 2 (human), 
Als2cr2
-11.03 -12.88 -1.75* -2.48
cctccatcctttatact NM_009536 tyrosine 3-
monooxygenase/
tryptophan 5-
monooxygenase 
activation protein, 
epsilon polypeptide, 
Ywhae
-3.19 -2.52 -1.82* -2.66
tgtgcttccctgtctta NM_008683 neural precursor cell 
expressed, 
developmentally down-
regulated gene 8, 
Nedd8
-4.73 -8.41 -1.83 -1.86
ctcctgaaggcatagtt NM_009454 ubiquitin-conjugating 
enzyme E2E 3, UBC4/5 
homolog (yeast), 
Ube2e3
-4.14 -5.52 -2.51 -3.22
gtgaaactaaaaaaaaa NM_009094 ribosomal protein S4, 
X-linked, Rps4x
-10.46 -19.19 -2.76 -3.35
aatgtttctgctttaca NM_011045 proliferating cell 
nuclear antigen, Pcna
-14.21 -8.30 -3.09 -2.62
cgtggatccctctgtca NM_009876 cyclin-dependent 
kinase inhibitor 1C 
(P57), Cdkn1c
-13.68 -7.16 -3.39* -3.30*
cctttgtgacagtggcc NM_025635 ZW10 interactor, 
Zwint
7.29 8.84 -3.47‡ -4.80‡
gaagccagtgggccatc NM_001033273 RIKEN cDNA 
5031439G07 gene, 
5031439G07Rik
-9.10 -10.00 -4.13 -3.65
gctgtgggtcgctgtgg NM_010561 interleukin enhancer 
binding factor 3, Ilf3
As As -4.15‡ -2.97‡
acccctgaccccttgtt NM_016707 B-cell CLL/lymphoma 
11A (zinc finger 
protein), Bcl11a
-7.88 -5.52 -4.42 -4.78
Table 3 (Continued)
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cggtgtcccccacctcc NM_012015 H2A histone family, 
member Y, H2afy
-21.48 -27.88 -4.62 -3.70
cagttgcaataaaaata NM_010894 neurogenic 
differentiation 1, 
Neurod1
-7.54 -4.96 -5.62 -5.10
aagtttgcaagtctcca NM_008538 myristoylated alanine 
rich protein kinase C 
substrate, Marcks
-24.87 -11.76 -5.72 -5.56
ttgctggcttttataaa NM_053104 RNA binding motif 
protein 9, Rbm9
-6.10 -7.82 -6.50 -5.97
ggttttgtttgtttgac NM_019653 WD repeat and SOCS 
box-containing 1, 
Wsb1
-7.88 -11.96 -6.54 -7.00
tatattgattgtggcaa NM_007569 B-cell translocation 
gene 1, anti-
proliferative, Btg1
-15.28 -16.48 -6.93 -5.58
taagaaacct NM_019413 roundabout homolog 1 
(Drosophila), Robo1
-28.64 -16.73 -8.23 -11.35
gctttgactgttctctt AA122503 EST from M2 cells of 
skin melanoma
-17.17 -18.68 -9.88 -10.15
tggagcgttggctgtat NM_009870 cyclin-dependent 
kinase 4, Cdk4
-114.55 -80.88 -14.77 -10.00
ctttccctgccaatgta NM_013834 secreted frizzled-
related protein 1, Sfrp1
Es Es -16.48 -16.37
tgcagctttctgttcaa NM_007971 enhancer of zeste 
homolog 2 
(Drosophila), Ezh2
-10.63 -5.52 -21.36 -17.59
cacgacaccccccaccc NM_009559 zinc finger protein 57, 
Zfp57
-30.72 -42.33 -29.13 -44.46
tgtgtgaggtgttgtga NM_010025 doublecortin, Dcx -44.41 -58.81 -73.76 -91.10
cagagtgtagtgtgttg NM_009234 SRY-box containing 
gene 11, Sox11
Es Es -140.05 -120.35
All RT-qPCR data are statistically significant at P < 0.001 unless specified: * P < 0.01; †P < 0.05. ‡A disagreement between RT-qPCR and SAGE data. 
As, adult-specific expression; Es, embryonic-specific expression; NS, no statistically significant difference between two developmental stages. Fold 
change values of <1.0 are presented in a negative fold change format.
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Table 4
RT-qPCR validation of SAGE profile for P1.5 versus adult stages
Fold change
SAGE tag RefSeq accession Gene ID Adult/P1.5 (SAGE) Adult/P1.5 (RT-qPCR)
aaattattgggaaatcc NM_011123 proteolipid protein (myelin) 1, Plp1 38.9 43.33
tttcagcagtgttggct NM_013556 hypoxanthine guanine phosphoribosyl 
transferase 1, Hprt1
6.99 2.26
actcggagccaccagac NM_009790 calmodulin 1, Calm1 4.57 1.83
gcttcgtccacacagcg NM_010777 myelin basic protein, Mbp As 1.79
tccccgtcat NM_026106 down-regulator of transcription 1, Dr1 Ps -1.46
gggaaactaagggagag NM_172503 zinc finger, SWIM domain containing 4, Zswim4 -42.42 -1.96*
gaacgcaagttcagccc NM_031404 actin-like 6B, Actl6b -5.51 -2.26
gtgaaactaaaaaaaaa NM_009094 ribosomal protein S4, X-linked, Rps4x -4.72 -2.27
Nil NM_009726 ATPase, Cu++ transporting, alpha polypeptide, 
Atp7a
Nil -2.91
agaagtgtttggagttt NM_008253 high mobility group box 3, Hmgb3 -20.99 -3.53
cctttgtgacagtggcc NM_025635 ZW10 interactor, Zwint 4.65 -4.04†
acagtctatgttggagg BQ177886/NM_010487 C57BL/6 whole brain E15.5 (or known as 
embryonic lethal, abnormal vision, Drosophila-
like 3 (Hu antigen C), Elavl3)
-41.99 -4.06
gatacttggaatgacta NM_007393 actin, beta, cytoplasmic, Actb -18.49 -4.35
ctggcttctt NM_008538 myristoylated alanine rich protein kinase C 
substrate, Marcks
Ps -4.76
Nil NM_025958 cullin-associated and neddylation-dissociated 2 
(putative), Cand2
Nil -5.62
gctttgactgttctctt NM_009870 cyclin-dependent kinase 4, Cdk4 -56.55 -5.77
ctcagtaatg AA122503 EST from M2 cells of skin melanoma -12.28 -11.12
tggagcgttggctgtat NM_009238 SRY-box containing gene 4, Sox4 -31.51 -11.74
cacgacaccccccaccc NM_007792 cysteine and glycine-rich protein 2, Csrp2 Ps -26.10
tgtgtgaggtgttgtga NM_009559 zinc finger protein 57, Zfp57 -16.33 -32.74
gggacctcgtggaagcc NM_010025 doublecortin, Dcx -24.56 -82.11
All RT-qPCR data are statistically significant at P < 0.001 unless specified: * P < 0.01. †A disagreement between RT-qPCR and SAGE data. As: adult-
specific expression; Nil: SAGE data not available; Ps: P1.5-specific expression. Fold change values of <1.0 are presented in a negative fold change 
format.
Table 5
RT-qPCR validation of SAGE profile for E15.5 versus P1.5 stages
Fold change
SAGE tag RefSeq accession Gene ID P1.5/E15.5 (SAGE) P1.5/E15.5 (RT-qPCR)
Atttctttggtgatttt NM_010838 microtubule-associated protein tau, Mapt 5.51 1.53*
Gcactgttaacaagtgt NM_009234 SRY-box containing gene 11, Sox11 -2.17 -3.32
All RT-qPCR data are statistically significant at P < 0.001 unless specified: * P < 0.05. Fold change values of <1.0 are presented in a negative fold 
change format.http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.11
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DETs are (in descending order of enrichment) Zfp57, Csrp2,
AA122503, Cdk4, Sox4, Marcks, Actb, BQ177889, Hmgb3,
Rps4x, Actl6b, Zswim4 and Dr1, whose expression ranges
from 33- to 1.4-fold greater than in the adult. On the other
hand, the Plp1 is expressed at a level 40 times greater in the
adult cerebral cortex compared to P1.5. Other validated genes
that are enriched in the adult cerebral cortex include (in
descending order) Hprt1, Calm1 and Mbp, with a 2.3- to 1.8-
fold greater expression than the P1.5 cerebral cortex. Com-
parison between E15.5 and P1.5 shows that Mapt has a 1.5-
fold greater expression level in the P1.5 cerebral cortex while
Sox11 expression is 3.3-fold lower (Table 5).
We  w e re  u na ble  t o v alida te  a ll 1 7  D ETs  fr om L  v er su s R i
regions, suggesting the left and right hemispheres of the adult
mouse cerebral cortex are highly similar and indistinguisha-
ble at the molecular level. SAGE and RT-qPCR analyses for R
versus C regions of E15.5 are discussed in a separate section
below.
Functional analysis of validated gene clusters using 
Ingenuity Pathway Analysis
The validated DETs of embryonic, adult and gene-switching
clusters were functionally characterized using proprietary
software, Ingenuity Pathway Analysis (IPA) from Ingenuity
Systems®, to identify enriched molecular networks and
canonical pathways. Given a list of input genes (known as
focus genes), IPA mapped these genes to a global molecular
network developed from information contained in the Inge-
nuity knowledge base (a manually curated database of exper-
imentally proven molecular interactions from published
literature). Networks of these focus genes were then algorith-
mically generated based on their connectivity. IPA deter-
mined the most significantly enriched biological functions
and/or related diseases by calculating the P-value using
Fisher's exact test. Using similar methods, significantly repre-
sented canonical pathways in a set of focus genes were also
determined using IPA (Section C in Additional data file 1).
From the embryonic-specific gene clusters, we identified two
statistically significant molecular networks (made up of 19
focus genes and 47 associated nodes; networks 1 and 2 in Fig-
ure 3; Figures S4 and S5 in Additional data file 1). The net-
works are interconnected through two genes, Marcks  and
Neurod1. In general, these networks are associated with cell
cycle and DNA replication, recombination and repair proc-
esses. Three statistically significant (using P < 0.05 as a cut-
off) canonical pathways are enriched in these networks
(Figure 3); Wnt/-catenin signaling (Sox4, Sox11 and Sfrp1),
P53 signaling (Cdk4 and Pcna) and tight junction signaling
(Cdk4  and  Actb) pathways. Validated DETs such as Btg1,
Cdk4, Cdkn1c, Csrp2, Ezh2, Neurod1, Pcna, and Rps4x are
associated with cell cycle control whereas Actb,  Ezh2,
Als2cr2, Marcks, Robo1 and Dcx are associated with cellular
assembly and organization. These processes are important in
the formation of filopodia, membrane blebs and growth cones
during neuronal growth, migration and axonogenesis. Known
human neurological disorders associated with the networks,
particularly network 2, include X-linked lissencephaly
(Online Mendelian Inheritance in Man [OMIM:300067];
DCX), juvenile onset dystonia ([OMIM:607371]; ACTB) and
Beckwith-Wiedemann syndrome ([OMIM:130600];
CDKN1C). All the DETs implicated in these networks are
expressed in the cortical plate with the exception of Pcna
(Table S5 in Additional data file 1) [31-42].
In adult-specific gene clusters, two molecular networks (18
focus genes and 50 associated nodes; networks 3 and 4 in Fig-
ure 3) were identified and interconnected via a single gene,
Mbp  (Figures S6 and S7 in Additional data file 1). These
molecular networks enrich for nine statistically significant
canonical pathways (P < 0.05) such as synaptic long-term
potentiation and depression, calcium signaling, B cell recep-
tor signaling, cAMP-mediated signaling, GM-CSF signaling,
amyotrophic lateral sclerosis signaling, G-protein-coupled
receptor signaling and xenobiotic metabolism signaling path-
ways. Validated DETs such as Camk2a, Gria3, Itpr1, Egr1,
Table 6
RT-qPCR validation of SAGE profile for rostral E15.5 and caudal E15.5 regions
Fold change
SAGE tag RefSeq accession Gene ID Caudal/rostral (SAGE) Caudal/rostral (RT-qPCR)
gttgttcttccagtcgg NM_016916 bladder cancer associated protein homolog 
(human), Blcap
2.68 1.43
gtcatagctgttctgtg BC025816 EST sequence BC025816 Cs 1.31 (NS)
aagcttgacatttggaa NM_026187 ankyrin repeat and zinc finger domain 
containing 1, Ankzf1
Rs 1.17† (NS)
gatacttggaatgacta NM_007393 actin, beta, cytoplasmic, Actb -2.63 -1.32
ttggtgaaggaaaaaac NM_021278 thymosin, beta 4, X chromosome, Tmsb4x -2.33 -2.13 (NS)
All RT-qPCR data are statistically significant at P < 0.05 unless specified. †A disagreement between RT-qPCR and SAGE data. Cs: caudal region-
specific expression; NS: no statistically significant difference between two developmental stages; Rs: rostral region-specific expression. Fold change 
values of <1.0 are presented in a negative fold change format.http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.12
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Rgs4, Gstm1 and Ppp3ca are associated with cell-to-cell com-
munication in the adult cerebral cortex. Biological functions
such as cell proliferation, movement and death processes are
also linked to these networks through the genes Camk2a,
Cryab,  Egr1,  Gstm1,  Itpr1,  Mbp,  Nrgn,  Ppp1r1b,  Ppp3ca,
Rgs4, Sept4, Sirpa and Sncb. Known human neurological dis-
orders associated with Network 3 include Pelizaeus-Merz-
bacher disease ([OMIM:312080]; PLP1) and dementia with
Lewy bodies ([OMIM:127750]; SNCB), whereas X-linked
mental retardation ([OMIM:300210]; TSPAN7 or TM4SF2)
is associated with network 4. MBP, found in both network 3
and 4, is associated with genetic susceptibility to multiple
sclerosis [OMIM:126200]. All the DETs implicated in these
networks are expressed in layers I to VI of the cerebral cortex,
with the exception of Gstm1 (layers II to V), Sirpa and Ppp3ca
(layers II to VI), and Nptxr (no expression data available)
(Table S5 in Additional data file 1) [32-34,43-52].
Both networks 5 and 6 (Figure 3) are linked to gene-switching
clusters. These two molecular networks (14 focus genes and
52 associated nodes) are associated with cellular morphogen-
esis, amino acid metabolism, cell death processes and devel-
opmental disorders (Figures S8 and S9 in Additional data file
1). These networks are connected by Ctsd and Ywhae and are
implicated in amyloid processing (App  and  Mapt), aryl
hydrocarbon receptor signaling (Ctsd and Nedd8) and cell
cycle G2/M DNA damage checkpoint regulation pathways
(Ywhae).  App,  Atp7a,  Hprt1,  Mapt,  Ctsd  and  Clcn2  are
involved in cell morphogenesis, assembly and organization.
Among all the networks in the study, network 5 has the great-
est number of DETs associated with known human neurolog-
ical disorders with six out of ten focus genes being associated
with known neurological disorders such as neuronal ceroid
lipofuscinosis ([OMIM:610127]; CTSD), Alzheimer's disease
([OMIM:104300]; APP), Menkes disease ([OMIM:309400];
ATP7A), X-linked cutis laxa ([OMIM:304150]; ATP7A), epi-
Novel molecular networks involved in cerebral corticogenesis Figure 3
Novel molecular networks involved in cerebral corticogenesis. The figure shows novel molecular networks, related biological functions/diseases, 
canonical pathways and known human neurological disorders based on Ingenuity Pathway Analysis and OMIM database. Detailed molecular interactions for 
all networks (indicated by asterisks) are illustrated in Figures S4, S5, S6, S7, S8 and S9 in Additional data file 1. Gene names next to arrow lines refer to 
common genes shared by two networks. Bold gene name refers to a focus gene. AN: associated nodes; FG: focused genes.http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.13
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lepsy ([OMIM:606904, 607628 and 607631]; CLCN2),
Lesch-Nyhan syndrome ([OMIM:300322]; HPRT1), fronto-
temporal dementia ([OMIM:600274]; MAPT), progressive
supranuclear palsy ([OMIM:601104]; MAPT) and Pick dis-
ease of the brain ([OMIM:172700]; MAPT). All the DETs
implicated in these networks are expressed in the cortical
plate during embryonic development with the exception of
Ube2e3. In the adult, all DETs are expressed in layers I to VI
of the cerebral cortex except for Bcl11a, Clcn2, Hprt1 (layers
II to VI), Atp7a and Ube2e3 (no expression was detected in
the adult cerebral cortex) (Table S5 in Additional data file 1)
[32-35,46,53-61].
To refine the functional analysis to a cellular level, we
grouped all 40 RT-qPCR validated DETs from networks 3, 4,
5 and 6 (adult specific and gene-switching gene clusters) into
three groups according to where they are expressed: only in
cortical neurons (N group); only in cortical glia (G group);
and in both cortical neurons and glia (B group). None of the
DETs from networks 1 and 2 (embryonic-specific gene clus-
ters) were analyzed because most of the cells within the cere-
bral cortex are committed to the neuronal lineage at E15.5.
The methods used to tabulate and group validated DETs are
detailed in Section D in Additional data file 1. DETs classified
as part of the N group are Bcl11a, Calm1, Camk2a, Camk2n1,
Hprt1, Itpr1, Mapt, Nedd8, Nrgn, Ppp1r1b, Ppp3ca, Rbm9,
Rgs4, Sncb and Ywhae, whereas those in the G group include
Cryab, Mbp, Nptxr, Plp1, Ppap2b, Sept4 and Tspan7. The B
group consists of App, Atp7a, Chgb, Ctsd, Egr1, Gria3, Gstm1
and Sirpa. DETs without any cellular expression information,
such as Actl6b,  Clcn2,  Hmgb3,  Ube2e3, AK138272,
AK139402, AK140219, AK154943, AU258168 and BQ176089,
were placed into group B to facilitate downstream analysis. Of
the 40 DETs, only 35 were mapped to the IPA knowledgebase
and subjected to further analysis. Functional analysis of these
35 DETs show that the neuron-based DETs (N and B groups)
are enriched for various human neurological disorders, such
as schizophrenia (9 DETs; P = 4.36E-8), Huntington's disease
(8 DETs; P = 1.03E-5), X-linked mental retardation (4 DETs;
P = 3.78E-7), Parkinson's disease (3 DETs; P = 6.99E-3) and
Alzheimer's disease (3 DETs; P = 1.52E-2) (Figure S10 in
Additional data file 1). Thirteen DETs associated with these
neurological disorders are also implicated in processes
related to cell death. Of these, eight DETs are expressed in
neurons only, two in glia only and three in both neurons and
glia.
From the above IPA analysis, Cand2 (embryonic gene clus-
ters), Camk2n1 (adult gene clusters), Hmgb3 (gene-switch-
ing clusters) and 10 ESTs (BQ176089, CD802535, AK139402,
AU258168, AK138272, AK140219, AK154943, AA122503,
NM_001033273 and BQ177886) are not currently connected
to any networks.
Regionalized expression of DETs in the E15.5 cerebral 
cortex
Early regionalized development is an important event that
could lay the foundations for adult arealization of cerebral
functions. To identify genes with regionalized expression pro-
files, we compared SAGE libraries generated from rostral and
caudal regions (equivalent to anterior and posterior regions
of the human cerebral cortex) of the E15.5 cerebral cortex. We
identified 44 DETs and selected 25 DETs (22 known genes, 1
EST and 2 ambiguous genes; Additional data file 2) and 2
genes of interest (bladder cancer associated protein, Blcap,
and ankyrin repeat and zinc finger domain containing 1,
Ankzf1) for RT-qPCR validation and further detailed region-
based analysis. This was done using independent biological
triplicates of clearly defined regions/quadrants, such as ros-
tro-lateral (RL), rostro-medial (RM), caudo-lateral (CL) and
caudo-medial (CM) of the E15.5 cerebral cortex (see Materials
and methods). Two positive controls with known regionalised
expression were included in the RT-qPCR: RAR-related
orphan receptor beta (Rorb) and nuclear receptor subfamily
2, group F, member 1 (Nr2f1). Rorb is highly expressed in the
rostral region whereas Nr2f1 is highly expressed in the caudal
region of the cerebral cortex [1,62].
An initial RT-qPCR analysis of combined RL and RM (rostral)
as well as CL and CM (caudal) regions shows upregulation of
Rorb and Nr2f1 in rostral and caudal regions, respectively
(based on fold change direction and magnitude of 1.3 times).
The same analysis also confirmed the SAGE data for 3 out of
25 DETs (Actb, Tmsb4x and BC025816) and Blcap (Table 6;
Additional data file 6). Both Actb and Tmsb4x have greater
expression in the rostral region whereas Blcap and BC025816
are greater in the caudal region. To identify expression pro-
files in a more refined area and prevent regional compensa-
tion due to combined quadrant analysis, we performed a
quadrant versus quadrant multiple regions comparison. The
largest number of DETs were found in the RL versus CM com-
parison, as they are the two developmentally most distinct
regions within the cerebral cortex at E15.5 compared to oth-
ers; RL versus CL > RM versus CL > RL versus RM = RM ver-
sus CM > CL versus CM. The region-specific expression
profiles were plotted for each of the DETs (Figure 4) and
grouped into two categories: RL-specific DETs, such as Actb,
Tmsb4x and cytochrome b-245, beta polypeptide (Cybb); and
CM-specific DETs, including Blcap, EST BC025816, Ankzf1
and cytochrome c oxidase I, mitochondrial (Cox1) (Additional
data file 6).
To visualize the regionalized expression profiles, we per-
formed in situ RNA hybridization (ISH) on all DETs validated
by quadrant versus quadrant RT-qPCR analysis, Blcap,
Ankzf1 as well as the positive controls Rorb and Nr2f1. We
performed ISH on sagittal and coronal sections (from rostral
to caudal regions) of the E15.5 mouse brain (Figure 5). Under
dark-field microscopic examination, we confirmed the
regionalized expression of Rorb (at the rostral cortical plate;http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.14
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Figure 5a) and Nr2f1 (at the caudal ventricular zone; Figure
5f). From the analysis, Actb is highly expressed at the cortical
plate and the subplate (Figure 5b). Tmsb4x  is highly
expressed at the cortical plate and the intermediate zone (Fig-
ure 5c-e).
ISH analysis showed that both Blcap and Ankzf1 are caudal
specific. Serial coronal sections from rostral to caudal regions
of the brain (Figure 5g-i) show Blcap is weakly expressed in
the rostral cerebral cortex, particularly at the intermediate
zone, subplate and the cortical plate, but is highly expressed
in the hippocampus and thalamus (Figure 5i). Ankzf1  is
expressed specifically in the ventricular zone as well as the
cortical plate towards the caudal region of the cerebral cortex
(Figure 5j-m). The distinctive expression of Ankzf1 in both the
ventricular zone and cerebral cortex prompted us to extend
our ISH analysis to various developmental stages starting
from E11.5 to adulthood (Figure 5n-t). Ankzf1 is expressed in
the primordial plexiform and the ventricular zone layers of
the telencephalon at E11.5 (Figure 5n). By E13.5, Ankzf1 is
weakly expressed in the ventricular zone, but is highly
expressed in the cortical plate (Figure 5o). From E17.5 to P1.5,
the expression of Ankzf1 is maintained in the cerebral cortex
(Figure 5p, q). In the adult, Ankzf1 expression is obvious in
the piriform cortex, hippocampus and cerebellum (Figure 5r-
t).
Genomic clustering of sense-antisense SAGE tags at 
the Sox4 and Sox11 loci
We performed genomic clustering analysis of the SAGE tags
to determine any actively transcribed chromosomal loci
throughout cerebral corticogenesis. Probabilities for chance
occurrences of two, three, four, and five DETs being clustered
within a window of ten adjacent tags present within each
chromosomal location, irrespective of genetic distance, were
calculated. This analysis was based on the DET lists described
above (Additional data file 2). The analysis showed two over-
represented chromosome loci at Sox4  and  Sox11, which
derive from embryonic-specific gene clusters.
At both loci, we observed multiple SAGE tags with both sense
and antisense orientations, which signify alternative polyade-
nylation sites, differential splicing and overlapping antisense
transcription. As an initial validation of the antisense mes-
sages, we performed strand-specific RT-PCR (Figure 6) using
cDNA synthesized from equally pooled total RNAs (three
RT-qPCR analysis of all R versus C DETs based on quadrant versus quadrant analysis Figure 4
RT-qPCR analysis of all R versus C DETs based on quadrant versus quadrant analysis. RL, RM, CL and CM denote rostro-lateral, rostro-
medial, caudo-lateral and caudo-medial regions of the cerebral cortex, respectively. OB denotes olfactory bulb. N = 3 per quadrant and data are presented 
as mean ± standard error of the mean. Fold change values (normalized to RL) are presented above the comparative bar and any values <1 are presented in 
the negative fold change format. Only the most significant fold change value is presented for each target gene. * P < 0.05; ** P < 0.01; *** P < 0.001.http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.15
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In situ RNA hybridization of selected R versus C regions of E15.5 DETs Figure 5
In situ RNA hybridization of selected R versus C regions of E15.5 DETs. ISH was performed on (a-m) E15.5 and (n-t) E11.5 to P150 brains. (g-
m) Coronal sections that are generated from the rostral to caudal axis; (a-f, s-t) sagittal sections. Micrographs of higher magnification are presented 
directly after any micrographs with an inset box (d-e, m, t). All micrographs are in dark-field except for (e, m), which are bright-field micrographs. C: 
caudal; CB: cerebellum; CP: cortical plate; DG: dentate gyrus; HPf: hippocampal formation; IZ: intermediate zone; OB: olfactory bulb; R: rostral; VZ: 
ventricular zone. Arrows show the region with expression or silver grains.
(a) (b) (c) (d)
(f) (g) (h) (i)
(j) (k) (l)
(n) (o) (p) (q) (r)
(s) (t)
(e)
(m)http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.16
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mice from each of E15.5, E17.5, P1.5 and adult stages). Three
primer sets were used for each locus (designed at the middle,
5'- and 3'-ends of the canonical transcripts). For both Sox4
and Sox11 loci, the analysis showed positive signals from all
primer sets used that were complementary to the antisense
strand, therefore confirming the presence of one or more
antisense transcript(s) that span the canonical transcript.
Hydroxymethylbilane synthase gene (Hmbs) served as a neg-
ative control and there were no positive bands in the anti-
sense strand RT-PCR, confirming the absence of antisense
transcripts.
Genomic cluster at the Sox4 gene locus
We mapped SAGE tags from the genomic cluster to the Sox4
gene locus using the University of California Santa Cruz
(UCSC) genome browser (Figure 7a; Additional data file 7)
[63]. Only tags within and around the Sox4 canonical tran-
script are shown. Evidence of mapped mouse mRNAs within
this locus further justifies the existence of multiple SAGE tags
in addition to the canonical Sox4 transcript. Subsequent vali-
dation of the genomic clusters was solely based on the SAGE
tags situated within the canonical transcript. Based on the
SAGE tag information, 6 out of 12 tags are DETs. These
include four DETs within the canonical transcript (Figure 7b),
with sox4_tag10 and sox4_tag15 having greater expression in
P1.5 compared to P150 (adult stage), whereas sox4_tag12 and
sox4_tag16 are both abundantly expressed in the caudal
region of the E15.5 cerebral cortex. Based on the RT-qPCR
analysis (Figure 7c), sox4_tag10 has greater expression in
E15.5 compared to E17.5 (1.76-fold change), P1.5 (3.72-fold
change) and Ad (43.67-fold change). For sox4_tag12,
sox4_tag15 and sox4_tag16, differences are seen only in P1.5
(-2.00-fold, -1.57-fold and -1.84-fold changes, respectively)
and Ad (-82.08-fold, -68.92-fold and -69.41-fold changes,
respectively) when compared to E15.5. RT-qPCR analysis on
the same tags did not find any differences between rostral and
caudal cerebral cortices of E15.5. The differences in fold
change between DETs suggest irregular overlapping of vari-
ous transcript variants at different Sox4 gene loci.
To further validate the expression profiles of the multiple
Sox4 DETs, we performed 3' rapid amplification of cDNA
ends (RACE)-Southern analysis using pooled adaptor-oligo-d
[T]15 synthesized cDNAs from three mice at each develop-
mental stage. Based on this method, we were able to semi-
quantitatively and accurately measure the expression levels of
individual SAGE tags at the locus. To show that the amplifica-
tion was cDNA specific, we performed PCR by using the same
primer sets on mouse genomic DNA under the same condi-
tions. In all cases, no amplification was observed (data not
shown). This analysis confirmed the presence of four out of
seven alternative transcripts for Sox4  (Figure 7d). Corre-
sponding tags were determined by estimating the amplicon
sizes between the strand-specific primers used, the next
downstream AAUAAA/AUUAAA polyadenylation signal (if
any) and succeeding CATG sequence or SAGE tags. Figure
7d(1)-d(3) confirms the existence of sox4_tag10, sox4_tag12
and sox4_tag15. Of these tags, SAGE expression profiles of
sox4_tag10 and sox4_tag15 were validated (embryonic-spe-
cific and reduced expression after P1.5) but not sox4_tag12
(E15.5 caudal region-specific). 3' RACE-Southern analysis
using a sense probe detected bands in the rostral and caudal
regions of E15.5, E15.5 and E17.5 cerebral cortices and, there-
fore, confirmed the existence of the Sox4  antisense tran-
scripts (Figure 7d(4)). Even though none of these tags were
differentially expressed in between these regions based on the
SAGE analysis, our findings show distinctive regionalization
for sox4_tag14 expression at the E15.5 rostral cerebral cortex.
Proteasome (prosome, macropain) subunit, beta type 2 gene
(Psmb2) and Hmbs were used as controls and no antisense or
alternative transcripts were identified at these gene loci (Fig-
ure 7d(5)-d(8)).
Since 3' RACE-Southern analysis was dependent on oligo-
[dT]15 priming, we could not rule out the possibility of ampli-
cons that were generated by false priming on homopolymer-
A stretches. Therefore, Northern analyses were performed on
equally pooled total RNA extracted from the cerebral cortices
of seven mice at E15.5, E17.5 and P150 (negative control). By
using a double-stranded DNA probe at the 3' untranslated
region (UTR) of Sox4 (Additional data file 8), we identified six
bands ranging from approximately 2 kb to approximately 4.7
kb (Figure 7e). Sox4 sense transcripts are weakly expressed in
Strand-specific RT-PCR Figure 6
Strand-specific RT-PCR. Lanes 1 to 6 represent the amplification of the 
Sox4 and Sox11 transcripts using more than one probe. Lane 7 shows the 
amplification of the Hmbs housekeeping gene whereas lane 8 represents 
the amplification of water as non-template control (NTC) using the primer 
set for Hmbs. The first panel consists of amplicons generated from the 
reverse-transcribed sense strand cDNA whereas the second panel 
consists of amplicons generated from the reverse-transcribed antisense 
strand cDNA. The third panel represents amplicons generated from oligo-
d [T]15 primed reverse-transcribed cDNA, which serves as a positive 
control. The last panel represents amplicons generated from primer-free 
reverse-transcription reactions. The numbers on the left indicate the size 
of the generated bands.
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Figure 7 (see legend on next page)
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the adult, but highly expressed in the embryonic cerebral cor-
tex. The number of bands observed is similar and corre-
sponds to overlapping mouse mRNAs as well as publicly
available paired-end diTag (PET) sequences downloaded
from Ensembl (Figure 7a; Table S6 in Additional data file 1)
[64]. Taken together, the analysis confirmed the existence of
multiple overlapping variants of Sox4 sense and antisense
transcripts at this gene locus.
To confirm the rostro-caudal expression of Sox4 sense tran-
scripts, we performed ISH on s a g i t t a l  s e c t i o n s  o f  m o u s e
brains using a Sox4 antisense riboprobe that spanned across
the sox4_tag10, sox4_tag12, sox4_tag15 and sox4_tag16
SAGE tags. Sox4 showed regionalized expression at E15.5 and
E17.5 (Figure 7f). At E15.5, Sox4  sense transcripts are
expressed more in both the rostral- and caudal-end regions of
the cortical plate compared to the intermediate region
between them (Figure 7f(1)). By E17.5, expression of Sox4
sense transcripts is obvious in the rostral cortical plate (Fig-
ure 7f(2)). At both stages of development, Sox4 sense tran-
scripts are uniformly expressed in the intermediate zone of
the cerebral cortex. These findings correspond to the SAGE
tag counts for E15.5 rostro-caudal regions of the cerebral cor-
tex (Figure 7f). These observations explain the averaged total
tag count per 100,000 tags for different Sox4  sense tran-
scripts, which are predominantly expressed in both rostral
and caudal regions of the cerebral cortex. The regionalized
expression of Sox4 in the cortical plate is obvious only at
E15.5 and E17.5, but not at other stages of development (Fig-
ure S11 in Additional data file 1).
In situ RNA hybridization of Sox4 sense and antisense 
transcripts
To further ascertain the antisense expression of Sox4 in a spa-
tio-temporal manner, we performed ISH on coronal sections
obtained from E11.5, E13.5, E15.5, E17.5, P1.5 and P150
mouse brains. Sense and antisense RNA probes were gener-
ated from the same clone used in the Northern analysis. At
E11.5, Sox4 sense transcripts are confined to the primordial
plexiform layer (Figure 8a). From E13.5 to P1.5, the sense
transcripts are expressed throughout the cortical plate (Fig-
ure 8b-e). Expression of sense transcripts in the subventricu-
lar zones is observed at E17.5 and P1.5 only (Figure 8d, e).
There is no observable sense expression in the adult stage
(Figure 8f). Sox4  antisense transcripts are expressed
throughout the telencephalon at E11.5 (Figure 8g). From
E13.5 to P1.5, Sox4 antisense expression is confined to the
cortical plate only (Figure 8h-k). There is no obvious anti-
sense expression in the cerebral cortex in the adult stage (Fig-
ure 8l). A microscopic examination at high magnification
showed that Sox4 antisense transcripts are predominantly
localized in the nucleus whereas Sox4 sense transcripts are
found in both the nucleus and cytoplasm (Figures S12, S13
and S14 in Additional data file 1). We used hemoglobin alpha,
adult chain 1 (Hba-a1) of the corresponding brain region and
time-point as a control in the analysis (Figure 8m-r).
Furthermore, Sox4 antisense expression occurs in the piri-
form cortex layer II (Figure 9a-c) and dentate gyrus (Figure
9g-i) in the adult brain; however, no sense expression is
observed in these regions. At P1.5, we identified complemen-
tary expression between Sox4 sense and antisense transcripts
in the olfactory bulb (Figure 9d-f). Sox4 sense expression was
confined to the granular and glomerular layers of the olfac-
tory bulb whereas antisense expression was found only in the
outer plexiform layer. We used either Sox11 or Hba-a1 of the
corresponding brain region and time-point as a control in the
analysis (Figure 9c, f, i).
Analysis of the Sox11 genomic cluster
SAGE tags, which represent multiple overlapping sense and
antisense transcript variants at the Sox11 genomic cluster,
were validated using 3' RACE-Southern analysis as described
above. See Section F in Additional data file 1 for a full descrip-
tion of the Sox11 results. ISH analysis did not confirm the
expression of antisense transcripts of Sox11, but the presence
of PETs spanning three out of five antisense tags confirmed
the existence of Sox11 antisense transcripts (Table S8 and Fig-
ures S16, S17 and S18 in Additional data file 1). The discrep-
ancy between ISH and RT-qPCR or 3' RACE-Southern
analysis suggests that Sox11 antisense transcripts might be
expressed at low levels or at specific locations of the cerebral
cortex, and hence can be detectable only by using serial sec-
tions or whole mount ISH.
Genomic cluster at the Sox4 locus Figure 7 (see previous page)
Genomic cluster at the Sox4 locus. (a) The UCSC genome browser of the over-represented Sox4 genomic locus. SAGE tags were found in both 
directions within the Sox4 reference gene. (b) The SAGE expression profiles for each tag in the Sox4 locus. (c) The RT-qPCR validations of selected DETs 
at various loci within the Sox4 canonical gene. (d) The 3' RACE-Southern blotting analysis. The left panel of the figure shows the sizes of the bands and 
their corresponding tags. (d1-d3) Amplification of Sox4 sense transcripts (ASP); (d4) amplification of Sox4 antisense transcripts (SP). Tags with asterisks are 
DETs. Both (d5) and (d7) are positive controls exclusively generated from the sense strand of Psmb2 and Hmbs housekeeping genes (ASP), respectively. 
The corresponding (d6) and (d8) are the antisense expression (negative control) of Psmb2 and Hmbs (SP), respectively. (e) Northern analysis of total RNA 
isolated from pooled mouse cerebral cortices (N = 7). (f) The regionalized expression of Sox4 sense transcripts determined by ISH. The table consists of 
SAGE information for related Sox4 sense tags at rostral and caudal regions of the E15.5 cerebral cortex. (f1) and (f2) are sagittal sections obtained from 
E15.5 and E17.5 mouse brains, respectively. The figures show the expression of the Sox4 sense transcript variants. Arrows show brain regions with greater 
Sox4 sense expression. C: caudal region of the cerebral cortex; R: rostral region of the cerebral cortex.http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.19
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Screening of Sox4 and Sox11 antisense transcripts in 
the adult mouse brain, organs, P19 cell line and 
neurospheres
We screened various adult brain regions (olfactory bulb, cer-
ebellum, medulla, hippocampus, thalamus and cerebral cor-
tex) and selected mouse organs (E15.5 whole brain, heart,
kidney, liver, skeletal muscle, skin, spleen, stomach, testis
and thymus) for the expression of Sox4 and Sox11 antisense
transcripts by strand-specific RT-qPCR. Within the adult
brain, Sox4 sense and antisense transcripts are expressed in
all regions, with the highest level found in the olfactory bulb,
which is approximately four- to nine-fold greater than those
in other brain regions (Figure 10a). Expression of Sox4 anti-
sense transcripts occurs in all mouse organs, with the highest
level in the thymus followed by E15.5 whole brain, testis and
skin (Figure 10b). Sox4 sense and antisense expression pro-
files are similar throughout the entire series of samples
screened, with the sense transcripts being consistently
expressed at a greater level than the antisense transcripts
(approximately 1.7-fold in various brain regions and approxi-
mately 2- to 14-fold in various organ comparisons).
Sox11 sense transcripts are expressed at the highest level in
the olfactory bulb, approximately two- to seven-fold greater
than those in other brain regions (Figure 10a). Sox11 anti-
sense transcripts, on the other hand, are expressed in all brain
regions screened and at a comparable level in the olfactory
bulb, hippocampus, thalamus and cerebral cortex. In com-
parison to other adult mouse organs, Sox11 sense and anti-
sense transcripts are highly expressed in the E15.5 whole
brain, with Sox11  sense transcript levels at least 100-fold
greater than those in other mouse organs (Figure 10b). On the
other hand, Sox11 antisense expression is observed only in the
E15.5 whole brain, skin and stomach. Notably, Sox11 sense
ISH analysis of Sox4 transcripts in E11.5 to P150 mouse brains Figure 8
ISH analysis of Sox4 transcripts in E11.5 to P150 mouse brains. (a-f) Expression of the sense transcript for Sox4. (g-l) The expression of the 
antisense transcript for Sox4. (m-r) Hba-a1 antisense expression (negative control). All micrographs were taken from coronal sections. CP: cortical plate; 
IZ: intermediate zone; MZ: marginal zone; PP: primordial plexiform layer; SVZ: subventricular zone; VZ: ventricular zone.
(a) (b) (c) (d) (e) (f)
(g) (h) (i) (j) (k) (l)
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transcripts are expressed more highly than antisense tran-
scripts in the E15.5 whole brain and skin (23- and 4-fold,
respectively).
Since both Sox4 and Sox11 are implicated in neuronal differ-
entiation and glial maturation processes [65,66], we exam-
ined both Sox4  and  Sox11  sense and antisense transcript
expression in proliferating and differentiating P19 (embryo-
nal carcinoma cells) and in embryonic NSPCs grown as neu-
rospheres. Both Sox4  sense and antisense transcripts are
upregulated during P19 cell differentiation (approximately
5.7- and 1.6-fold upregulation, respectively; Figure 11a) and
neurosphere differentiation (approximately 1.9- and 1.8-fold
upregulation, respectively; Figure 11b). For Sox11, both sense
and antisense transcripts are upregulated in the differentiat-
ing compared to the proliferating P19 cells by approximately
2.3- and 4.2-fold, respectively (Figure 11c). Both the Sox11
sense and antisense transcripts are, however, downregulated
in the differentiating neurospheres (approximately 2.6- and
1.5-fold, respectively; Figure 11d).
Discussion
In this study, SAGE was used to analyze global gene expres-
sion in the normal mouse cerebral cortex at various develop-
mental stages. We report validated spatio-temporal
regulation of genes involved in mouse cerebral cortex devel-
opment from embryo to adulthood. The study highlights four
main findings: association of DETs from different gene clus-
ters with known functional processes or signaling pathways
and disease-causative genes that are involved in cerebral cor-
ticogenesis; Ankzf1 and Sox4 sense transcripts are regionally
expressed in the E15.5 cerebral cortex; multiple overlapping
Sox4 and Sox11 sense and antisense transcripts are spatio-
Sox4 antisense expression in other brain regions Figure 9
Sox4 antisense expression in other brain regions. (a-i) Sox4 antisense expression is also observed in other regions such as the piriform cortex (a-c; 
arrows), olfactory bulb (d-f) and dentate gyrus (g-i). (a, d, g) Sox4 sense expression; (b, e, h) Sox4 antisense expression. (c, f, i) Hba-a1 or Sox11 antisense 
expression (negative controls). All micrographs were taken from sagittal sections except (a-c), which were taken from coronal sections. gl: glomerular 
layer; gr: granule layer; Opl: outer plexiform layer; PIR2: piriform cortex layer II.
(b)
(a) (d)
(c)
(e)
(f)
(g)
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Expression of Sox4 and Sox11 transcripts in various mouse organs Figure 10
Expression of Sox4 and Sox11 transcripts in various mouse organs. (a) Strand-specific RT-qPCR screening of Sox4 and Sox11 sense and antisense 
transcript expression in various adult mouse brain regions. N = 2 and data are presented as mean ± standard error of the mean (SEM). (b) Strand-specific 
RT-qPCR screening of Sox4 and Sox11 sense and antisense transcripts in various adult mouse organs. N = 3 and data are presented as mean ± SEM.
(a)
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temporally regulated during cerebral corticogenesis; and
Sox4 and Sox11 antisense transcripts are differentially regu-
lated in both proliferating and differentiating embryonic-
derived neurospheres and P19 cells.
We have shown that most tags generated in all libraries were
singletons. The number of singletons could be reduced by
increasing the number of tags sequenced. In mammalian
cells, the number of additional unique transcripts identified
approached zero when the number of SAGE tags sequenced
reached approximately 600,000 [67]. Increasing the number
of tags sequenced could improve the sensitivity of the tech-
nique to identify weakly expressed or novel transcripts, and
the application of massively parallel signature sequencing
[68] using a next-generation sequencer would be an ideal
solution to accomplish this. In addition, one of the benefits of
SAGE is that datasets generated from different groups or in
public repositories such as SAGE Genie [69] and GEO [28]
are readily comparable and, hence, can increase the tag count
and sensitivity of the technique in discovering DETs between
SAGE libraries. However, any meta-analyses involving vari-
ous SAGE datasets are affected by experimental and biologi-
cal variation; thus, a careful selection of matching libraries is
crucial to limit systematic error or biases.
Our SAGE analysis robustly detected DETs with a low false
positive rate (for example, <0.001% for comparison between
left and right hemispheres of the adult cerebral cortex). Of all
the identified DETs, approximately 8% were not mapped to
either a single locus in the mouse genome or any unique
annotation. This problem could be overcome by generating
additional information from the 5' end of the transcript
through alternative techniques such as PET sequencing [70],
cap analysis gene expression (CAGE) [71] and 5' LongSAGE
[72].
We have identified functional ontologies, molecular interac-
tions and enriched canonical pathways that are distinct to the
Expression of Sox4 and Sox11 transcripts in neuropsheres and P19 cells Figure 11
Expression of Sox4 and Sox11 transcripts in neuropsheres and P19 cells. (a-d) The figure shows strand-specific RT-qPCR screening of Sox4 (a, b) 
and Sox11 (c, d) sense and antisense transcripts expression in proliferating and differentiating P19 cells (a, c) and neuropsheres (b, d). N = 3 for P19 cells 
and N = 2 for neuropsheres. All data are presented as mean ± standard error of the mean. Fold change values (normalization to proliferating cells) are 
presented above the comparative bar and any values <1 are presented in the negative fold change format. * P < 0.05; ** P < 0.01; *** P < 0.001.
(a)
(c)
(b)
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stage-specific gene clusters of validated DETs. The IPA net-
work analysis generated connections between validated DETs
across various developmental stages in relation to well-estab-
lished proteins or molecules and neurological disorders. In
the study, members of the Wnt/-catenin signaling pathway
were enriched in networks 1 and 2 (embryonic-specific gene
clusters). In neural development, Wnt/-catenin signaling
plays an important role in regulating regional specification of
the cortex along the rostro-caudal and dorso-ventral axes,
and proliferation of cortical progenitors [73]. IPA highlighted
three genes (Sox4, Sox11 and Sfrp1) associated with this path-
way. In humans, the SFRP1 protein (secreted frizzled-related
protein 1) stabilizes -catenin and increases transcription
from -catenin-responsive promoters [74]. In -catenin-defi-
cient mouse mutants, expression of both Sox4 and Sox11 is
downregulated [75,76]. Sox4 and Sox11 proteins play an
important role in establishing neuronal properties, pan-neu-
ronal gene expression and proper myelination of the central
nervous system [65,66]. This suggests that the role of the
Wnt/-catenin signaling pathway in regulating neuronal
development could be mediated, at least in part, by the Sox4
and Sox11 proteins.
The role of Wnt/-catenin signaling in regulating DETs (Btg1,
Cdk4,  Cdkn1c,  Csrp2,  Ezh2,  Neurod1,  Pcna, and Rps4x)
involved in cell cycle and proliferation remains unclear. Gain-
and loss-of-function studies have established that Wnt/-cat-
enin signaling is essential to maintain the pool of precursors
for proper development of the cerebral cortex [77,78]. To
date, there is no direct evidence to show that Ezh2, Pcna,
Rps4x and Btg1 are involved in cell cycle regulation during
early embryonic neurogenesis. But their expression in the
ventricular/subventricular zone of the E15.5 developing
mouse cerebral cortex [33,35,36] suggests that they may be
involved in regulating cell proliferation during neurogenesis.
The role of these DETs and their association with the Wnt/-
catenin signaling pathway remains unclear and requires fur-
ther experimentation.
Networks 3 and 4 from the adult gene cluster were associated
with various canonical pathways, in particular, synaptic long
term potentiation (LTP) and calcium signaling. LTP is a proc-
ess of synapse enhancement, which is thought to underlie
some forms of learning and memory [79]. This process
depends on Ca2+ and calmodulin, which are major compo-
nents of the calcium signaling pathway. We identified four
DETs, Gria3, Itpr1, Ppp3ca and Camk2a, in both canonical
pathways. In particular, the Camk2a enzyme is highly
expressed in the brain and regulates mainly glutamatergic
synapses during LTP [79]. DET products such as Nrgn and
Camk2n1 can directly or indirectly regulate Camk2a or Ca2+/
calmodulin and subsequently alter the outcome of the LTP
pathway [80,81]. Therefore, they may serve as important can-
didate genes in the future analysis of the synaptic LTP path-
way involving neurodegenerative diseases that cause the loss
of cognitive function and memory.
Networks 5 and 6 are enriched for genes in the amyloid
processing signaling pathway. App and Mapt are associated
with this pathway. Under normal circumstances, the App pro-
tein is required for proper migration of neuronal precursors
into the cortical plate in early embryonic corticogenesis [82].
The Mapt protein, on the other hand, plays an important role
in maintaining the architecture of the neuronal cytoskeleton
and intracellular trafficking. Overexpression of App protein
and hyperphosphorylation of the Mapt protein have been
implicated in the pathologies of Alzheimer's disease [83,84].
Interestingly,  Ctsd,  Atp7a,  Clcn2  and  Hprt1, the genes
responsible for other human neurological disorders such as
neuronal ceroid lipofuscinosis (Ctsd), Menkes disease
(Atp7a), epilepsy (Clcn2), and Lesch-Nyhan syndrome
(Hprt1), are associated with App and Mapt. These candidate
genes are also involved in cell morphogenesis, assembly and
organization and could be linked to deterioration of neurons
during the pathologic progression of these disorders.
Pathway analysis of DETs classified into the N, G and B
groups showed DETs in the neuron (N and B groups) are
associated with Huntington's disease and schizophrenia,
which were not previously identified in networks 3 to 6. Our
analysis showed that both disorders share three common
DETs, namely Rgs4, Ppp1r1b and Chgb, whose expression is
downregulated in humans with Huntington's disease or
schizophrenia [85-88]. A proportion of patients with Hunt-
ington's disease also develop schizophrenia [89,90]. Taken
together, downregulation of Rgs4, Ppp1r1b and Chgb expres-
sion in neurons may contribute to the common symptoms in
these disorders. Our findings imply that many DETs (includ-
ing App, Hprt1 and Sncb) associated with both Huntington's
disease and schizophrenia are also involved in neuronal/cell
death processes [91-93]. Other DETs in the N group, not pre-
viously implicated in neuronal cell death, may serve as novel
potential candidates during pathologic development in these
disorders.
Regionalized development of the cerebral cortex involves the
differential regulation of cell cycle exit, early migration and
attainment of positional identity in neuronal fated cells. To
date, only few genes have been associated with regionalized
development of the cerebral cortex [3,94]. In the regionaliza-
tion analysis, we identified the highest number of DETs in the
comparison of the RL and CM libraries, which signifies that
these two regions of the cerebral cortex are the most different.
This finding supports the notion that the cerebral cortex is
developed in a latero-medial axis followed by a rostro-caudal
axis [7,8]. At E15.5, both Actb and Tmsb4x were expressed
greater in the rostral cerebral cortex than in the caudal region.
Both Actb and Tmsb4x proteins are involved in the actin
cytoskeleton-signaling pathway [95]. In particular, the
Tmsb4x protein has been shown to promote cardiomyocyte
migration [96] and axonal tract growth in zebrafish [97].
Therefore, co-expression of Actb and Tmsb4x in the E15.5
mouse cortical plate suggests that they may have a synergistichttp://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.24
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role in early cortical cell development. Conversely, Blcap and
Ankzf1 were expressed more highly in the caudal than in the
rostral region of the E15.5 cerebral cortex. To date, the func-
tion of both Blcap and Ankzf1 in the cerebral cortex remains
uncharacterized. This study provides the first comprehensive
expression profile of Ankzf1  and suggests it could be an
important transcription factor in cerebral corticogenesis.
At E15.5, Sox4 sense transcripts were expressed in a high-ros-
tral and high-caudal manner with lesser expression within
the intermediate region. By E17.5, Sox4 expression becomes
obvious at the rostral cortical plate, which is similar to Rorb.
But, we did not find that the regionalized expression of Sox4
sense transcripts resembles that of the restricted Rorb
expression at E15.5 or in the postnatal brain [1,62]. This find-
ing could be caused by the combined expression profiles of
different Sox4 sense transcripts that are present across the
rostro-caudal axis of the cortical plate. The regionalized
expression of Sox4  sense transcripts occurs only between
E15.5 and E17.5. Because the thalamic axon innervates the
cortical plate after E17.5 [98], the regionalization of Sox4
sense transcripts in early cortical development could be an
outcome of an intrinsic instead of an extrinsic mechanism
that regulates early patterning of the cerebral cortex.
Genomic clustering of DETs identified the differentially regu-
lated Sox4 and Sox11 gene loci. These genomic clusters imply
that there are multiple overlapping sense and antisense tran-
scripts surrounding the same gene locus that are co-tran-
scribed simultaneously during cerebral cortex development.
Both Sox4 and Sox11 are single exon genes and these tran-
script variants are therefore likely to be generated due to
alternative polyadenylation. The 3' UTRs of both Sox4 and
Sox11 have tandem terminal polyadenylation signals on both
sense and antisense strands (data not shown), which supports
the occurrence of multiple transcript forms or SAGE tags.
Multiple mRNA forms with different 3' UTRs can lead to cell-
specific regulation, different nuclear or cytoplasmic mRNA
stability and translation rates [99,100]. The 3' UTR of Sox4
and Sox11 may contain AU-rich elements that play an impor-
tant role in determining mRNA stability through deadenyla-
tion, decapping or 3'  5' decay [101]. Besides, different 3'
UTR lengths may be targeted by different miRNAs, thus
interfering with the translation process. Both Sox4 and Sox11
transcripts may be targeted by various miRNAs at different
predicted positions across the 3' UTR (Tables S7 and S9 and
Figures S15 and S18 in Additional data file 1). Therefore, 3'
UTR lengths of Sox4 and Sox11 may be an important feature
in the regulation of their protein expression during cerebral
corticogenesis.
In the study, NATs were found at both the Sox4 and Sox11
gene loci overlapping the sense transcripts. Overlapping
NATs may function as templates for the generation of pre-
miRNA and mature miRNA with exceptional high sequence
conservation that complement the overlapping sense protein-
coding transcripts [102]. To date, no mature or pre-miRNAs
have been predicted on the Sox4 and Sox11 sense and anti-
sense strands (data not shown) or have been reported in miR-
Base [103]. In addition, NATs can self-complement to form
double stranded RNA or pair with sense transcripts and func-
tion as templates for the generation of endogenous small
interfering RNAs, which could subsequently interfere with
translation or transcription of multiple protein-coding tran-
scripts [104]. Because both Sox4 and Sox11 proteins are
highly expressed in the cerebral cortex, the overlapping NATs
do not seem to be involved in the regulation of Sox4 and Sox11
through miRNA- or small interfering RNA-mediated transla-
tion repression mechanisms, but rather through antisense-
regulated sense transcription within the nucleus.
Our ISH analysis showed complementary cellular expression
profiles of Sox4 sense and antisense transcripts at the piri-
form cortex, olfactory bulb and dentate gyrus. This finding
implies that Sox4 antisense transcripts may be essential in
intracellular and interlocus negative feedback loop regulation
of the Sox4 sense transcripts. Similar expression profiles of
Sox4  sense and antisense transcripts in multiple mouse
organs and brain regions, however, suggest that these tran-
scripts may be co-expressed. This observation is also sup-
ported by the temporal co-expression of Sox4  sense and
antisense transcripts in the cortical plate or layers I to III of
the cerebral cortex. Taken together, the sense and antisense
transcripts of Sox4  are co-expressed in some cells and
expressed complementarily in other cells, suggesting crucial
cell-type-specific regulation.
Sox4 and Sox11 have been shown to have redundant roles
during mouse development [105], and Sox11 may play a com-
pensatory role in the absence of Sox4 during brain develop-
ment [106]. We demonstrated that Sox4 and Sox11 sense and
antisense transcripts have a similar expression in the brain,
but not in other organs, suggesting a compensatory role for
Sox11 only in the brain. Sox11  antisense transcripts were
expressed in the brain, skin and stomach only, suggesting
organ-specific regulation.
Our data show upregulation of Sox4 and Sox11 sense tran-
scripts in differentiating P19 cells, consistent with the find-
ings of others [107,108], and demonstrate upregulation of
antisense transcripts as well. We also find both Sox4  and
Sox11 sense transcripts expressed in the NSPCs cultured as
neurospheres, which is in agreement with Dy et al. [109]. Fur-
thermore, we identify upregulation of both Sox4 sense and
antisense transcripts but downregulation of Sox11 sense tran-
scripts in differentiating neurospheres. Taken together, our
findings show that there are potentially common and distinct
roles for Sox4 and Sox11 sense and antisense transcripts dur-
ing neuronal and non-neuronal cell proliferation and differ-
entiation. The underlying regulatory mechanism of these
transcripts, particularly the antisense ones, remains
unknown and requires further investigation.http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.25
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Conclusions
This study provides avenues for future research focus in
understanding the fundamental processes and development
of neurological disorders related to the cerebral cortex. We
confirm the regionalized expression of new candidate genes
in the E15.5 cerebral cortex as well as differential regulation
of multiple overlapping sense and novel antisense transcripts
within Sox4 and Sox11 gene loci during cerebral corticogene-
sis. We also report for the first time the spatio-temporal reg-
ulation of Sox4 antisense transcripts in the brain as well as
differential regulation of novel Sox4  and  Sox11  antisense
transcripts in various mouse organs and in proliferating and
differentiating NSPCs and P19 cells. The finding provides an
insight for future investigations into the role of antisense
transcripts during cerebral corticogenesis and neuronal dif-
ferentiation.
Materials and methods
Serial analysis of gene expression
Handling of animals and dissection of the cerebral cortex
All experiments that involved animal breeding and handling
were performed according to protocols approved by the Mel-
bourne Health Animal Ethics Committee (Project numbers
2001.045 and 2004.041). All animals involved in the study
were C57BL/6 mice unless specified otherwise. All mice were
kept under conditions of a 12-h light/12-h dark cycle with
unlimited access to food and water. All mice were culled by
cervical dislocation prior to dissection. Cortical tissue was
procured in the following fashion. For adult samples, after
removal of the meninges, coronal cuts were used to excise the
olfactory bulb from the rostral region, and the superior collic-
ulus from the caudal region. A sagittal cut to separate the two
cortical hemispheres was performed. The cortical pallium
was dissected from the subpallial striatum and the septum.
The neocortex was then dissected away from the cingulate
cortex and the entorhinal cortex. For embryonic samples, the
cortical tissue was dissected free from the underlying gangli-
onic eminences at the pallial-subpallial border. An orthogo-
nal cut was made to remove the presumptive striatum and the
overlying piriform cortex. On the medial aspect, the medial
limbic cortex was included for analysis, but the adjacent hip-
pocampal primordium, including the cortical hem, was
excluded. For the E15.5 cerebral cortex, the resulting hemi-
spheres containing cortical tissue only were placed on the
bottom of the Petri dish and, using a fine scalpel, divided into
four equal quadrants per hemisphere, namely RL, RM, CL
and CM. Rostral and caudal quadrants from both hemi-
spheres were pooled for SAGE library construction but sepa-
rately tracked for RT-qPCR analysis. Procurement of other
adult brain tissues and related mouse organs for Sox4 and
Sox11 antisense transcript screening was carried out accord-
ing to the standard mouse necropsy protocol accessible at the
National Institute of Allergy and Infectious Diseases (NIAID)
website [110].
SAGE libraries and analysis of tags
Ten SAGE libraries were constructed from the cerebral cortex
of E15.5, E17.5 and 4- to 6-month-old (Ad) mice according to
either one of the two methods described previously [25,26],
using I-SAGE™ or I-SAGE™ Long Kits (Invitrogen, Mul-
grave, Victoria, Australia). Additional libraries from E15.5
and P1.5 of the cerebral cortex described previously [27] were
also included in the analysis. These libraries contain a total of
26,436 traces. SAGE tags were preprocessed - that is, TAGs
were extracted and corrected for sequencing errors, and arti-
facts like SAGE linkers, ribosomal RNA and duplicated ditags
were removed using the 'sagenhaft' package, which is availa-
ble from the Bioconductor website [111,112]. To compare
libraries that contain long tags with those that contain short
tags, all short tags were mapped to the existing long tags from
the other libraries. A table for all libraries containing the
unique long or short tags was generated and redundant tags
were removed. Only tags with a total count >2 (across all
libraries) were considered for subsequent comparisons. Each
unique tag was mapped to the mouse genome using EST-
graph, which employs ESTs and their genomic position infor-
mation. ESTgraph was created by Tim Beissbarth
(unpublished) [113]. Identity was assigned to these tags and
they were further grouped into the following categories:
matching to a gene, a genomic sequence, or an EST, or ambig-
uous matches or no alignment at all. All annotations were
based on the latest mouse assembly (mm9 released in July
2007) accessible from the UCSC Genome Bioinformatics
website [63].
Identification of differentially expressed tags
Library comparisons were performed using two methods.
Fisher's exact test was used to compare two individual SAGE
libraries. In the analysis, multiple testing correction [114] was
carried out to control for false-discovery rate and adjusted P-
value cutoffs (Q-values) were used to select DETs. In cases
where several libraries were combined to focus on a specific
biological comparison (for example, different stages of devel-
opment), a Bayesian model, as described previously [115],
was used to integrate multiple libraries in pairwise compari-
sons involving biological replicates of libraries. The model
accounts for within-class variability by means of mixture dis-
tributions. The resulting E-values were used to select DETs. A
table of all relevant comparisons, the comparison method and
Q- or E-value cutoffs is provided in Table S1 in Additional
data file 1.
Hierarchical clustering of SAGE tags
To identify co-regulated genes, the clustering of DETs was
performed based on the log2 of normalized counts. Each
library was normalized to 100,000 tags per library to account
for size differences. A pseudocount of 0.5 was added before
taking the log2 of the normalized tag counts. The tag-wise
mean was subtracted from the log2 tag intensities before
computing the Euclidean distance of the individual tag pro-
files. Hierarchical clustering was performed on the tags usinghttp://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.26
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the 'hclust' function and complete linkage, which was imple-
mented using the statistical computing environment of R
[116].
Genomic clustering of SAGE tags
To assess whether there was any genomic clustering of tags, a
method previously described [117] was adopted. In brief, first
gene lists (based on all DETs in both pairwise and multiple
library comparisons as well as gene lists from the hierarchical
clustering analysis) were selected. The genomic clustering of
either of these selections was compared to the total unique tag
list (all 25,165 unique tags). The tags were mapped to the
mouse genome. The number of selected tags in ten consecu-
tive tag positions for each window of the chromosome was
calculated. One thousand permutations were used to com-
pute the null distribution of maximum tag counts per win-
dow. The method was implemented using the statistical
computing environment of R [116].
Functional classification and characterization of DETs
Gene Ontology enrichment analysis
The DET lists generated from various comparisons were sub-
jected to systematic functional annotation using the stand-
ardized Gene Ontology term analysis tools at the DAVID [30].
Functional clustering was performed using high stringency
with a kappa similarity threshold of 0.85 and a minimum
term overlap of 3. Classification was carried out using a mul-
tiple linkage threshold of 0.5 with both numbers of initial and
final group members set to 3. A term was considered statisti-
cally significant when the computed P-value was < 0.05. All
queries were performed in September 2009.
Molecular interactions and pathway analysis
Identification of molecular network interactions and pathway
analysis of validated DETs or co-regulated genes was com-
pleted using the IPA [118] tools from Ingenuity Systems®
(Redwood City, California, USA). Accession numbers for all
genes with their corresponding fold changes or normalized
counts were imported into the IPA software. No focus genes
were set at the beginning of the analysis. To start building net-
works, the application queries the list of input genes and all
other gene objects stored in the Ingenuity knowledge base.
Networks with a maximum of 30 genes or proteins were con-
structed, and scores were computed based on the likelihood
of the genes being connected together due to random chance.
A score of 2 indicates that there is a 1/100 chance that these
genes are connected in a network due to random chance.
Therefore, any networks with a score of 2 or above are consid-
ered statistically significant (with >99% confidence). The
most significant novel networks and their interactions with
existing canonical pathways were investigated further.
Quantitative RT-PCR
Total RNA isolation and first strand cDNA synthesis
RT-qPCR was carried out to validate all selected candidate or
co-regulated DETs. Biological triplicates from E15.5, E17.5,
P1.5 and adult (5 to 6 months old) cerebral cortices were used.
Genomic-free total RNA from independent mice was
extracted using the RNeasy® Lipid Tissue Midi Kit (Qiagen,
Doncaster, Victoria, Australia) according to the manufac-
turer's protocol (Section G in Additional data file 1). First
strand cDNA was synthesized from high quality total RNA
[119] using random hexamers (unless specified otherwise)
and the SuperScript™ III Reverse Transcriptase Kit (Invitro-
gen, Mulgrave, Victoria, Australia), according to the manu-
facturer's protocol, under an RNAse-free environment.
Primer design and RT-qPCR
All primers were designed using ProbeFinder 2.35 at the
Assay Design Center for Universal ProbeLibrary Assay pro-
vided by Roche Applied Science [120]. All RT-qPCR reactions
were prepared in 10 l volumes in a 384-well plate format
consisting of LC480 Master Probe Mix (Roche Diagnostics,
Castle Hill, New South Wales, Australia), Universal
ProbeLibrary (Roche Diagnostics, Castle Hill, New South
Wales, Australia) and forward and reverse primers
(GeneWorks, Hindmarsh, South Australia, Australia or
Bioneer Corporation, Daedeok-gu, Daejeon, Korea) accord-
ing to the manufacturers' protocols. RT-qPCRs were per-
formed using the LightCycler®  480 System (Roche
Diagnostics, Castle Hill, New South Wales, Australia) accord-
ing to the manufacturer's protocol (Section G in Additional
data file 1). A full list of primers and probes used in this study
is included in Additional data file 8.
Relative quantification using a standard curve method
The crossing point (Cp) from each signal was calculated based
on the Second Derivative Maximum method [121]. A set of
serially diluted cDNAs was used to construct a four-data point
standard curve for every PCR system in each run. A total of
three reference genes (from Hprt1, Psmb2, phosphoglycerate
kinase 1 gene (Pgk1) or Hmbs) were used as endogenous con-
trols. An estimated starting amount of each target gene was
calculated and intra-samples multiple reference genes nor-
malization was performed (Section G in Additional data file
1). A linear model was fitted to the time course of expression
values for each gene. Genes differentially expressed between
the various stages of development or regions were selected
using empirical Bayesian moderated t-statistics, which bor-
row information between genes [122]. Standard errors for the
mean expression at various developmental stages were
obtained from the linear model. For each comparison, P-val-
ues were adjusted using the Benjamini and Hochberg [114]
method to control the false discovery rate. See Section H in
Additional data file 1 for the R code used to execute the anal-
ysis.
Validation of sense-antisense and multiple overlapping 
transcripts in genomic clusters
Strand specific RT-PCR
All RNA was prepared as described above. Total RNA from all
developmental stages (N = 3 per developmental stage) washttp://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.27
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e q u a l l y  p o o l e d  p r i o r  t o  c D N A  s y n t h e s i s .  F o u r  f i r s t  s t r a n d
cDNA synthesis reactions were prepared for each cluster as
follows: with a primer complementary to the sense strand
only; with a primer complementary to the antisense strand
only; with oligo-d [T]15 as a positive control; and without any
primers as a negative control. In all four reactions, both prim-
ers were added in subsequent PCRs (Section G in Additional
data file 1). PCR amplifications were carried out using Fast-
Start PCR High Fidelity System (Roche Diagnostics, Castle
Hill, New South Wales, Australia) according to the manufac-
turer's protocol. More than one primer set was used in the
sense-antisense strand specific RT-PCR (Additional data file
8).
RACE
First strand cDNA synthesis was carried out using pooled
total RNA extracted from three biological replicates of rostral
and caudal E15.5 and whole E15.5, E17.5, P1.5 and adult (5 to
6 months old) cerebral cortices. Oligo-d [T]15 with an adaptor
sequence (5'-TACGACGTCTGCTAGGACTG-3') was used to
prime the first strand cDNA synthesis. Second strand synthe-
sis or PCR was then carried out using a strand-specific primer
and the adaptor primers (Additional data file 8). All specific
primers were designed to be complementary to the SAGE tags
or their upstream sequences. PCR amplifications (Section G
in Additional data file 1) were carried out using FastStart PCR
High Fidelity System (Roche Diagnostics, Castle Hill, New
South Wales, Australia) according to the manufacturer's pro-
tocol.
Southern blotting analysis
A m p l i f i e d  3 '  R A C E  p r o d u c t s  w e r e  t r a n s f e r r e d  t o  H y b o n d
N+TM (GE Healthcare, Rydalmere, New South Wales, Aus-
tralia) nylon membrane using the neutral transfer method.
Prehybridization and hybridization steps were performed in
Rapid-Hyb buffer (GE Healthcare, Rydalmere, New South
Wales, Australia) according to the manufacturer's protocol.
All oligonucleotides were designed to be complementary to
sequence between the specific primer-priming site and the
tag of interest. Synthetic oligonucleotides were 5' end-labeled
using T4 polynucleotide kinase (Promega, Alexandria, New
South Wales, Australia) and [-32P]ATP (GE Healthcare,
Rydalmere, New South Wales, Australia) with modifications
to the manufacturer's protocol. After the hybridization step,
the membrane was washed with 5× sodium chloride sodium
citrate solution (with 0.1% v/v sodium dodecyl sulphate
(SDS)) and 1× sodium chloride sodium citrate solution (with
0.1% w/v SDS) (Section G in Additional data file 1). See Addi-
tional data file 8 for primer sequences and oligonucleotides
used for detection.
Northern blotting analysis
Independent preparations of total RNA from the cerebral cor-
tex of seven mice at E15.5 and E17.5, and three adult mice
were equally pooled to a final concentration of 20 g per
developmental stage. These pooled total RNAs were electro-
phoresed overnight and capillary transferred onto Hybond
N+TM (GE Healthcare, Rydalmere, New South Wales, Aus-
tralia) nylon membrane. Double-stranded DNA probes were
radioactive-labeled using the Amersham Megaprime DNA
Labeling System (GE Healthcare, Rydalmere, New South
Wales, Australia) and [-32P]CTP, according to the manufac-
turer's protocol. Hybridization was carried out overnight
(approximately 18 h) at 65°C in aqueous buffer (7% w/v SDS
with 0.5 M phosphate). After hybridization, blots were
washed using 1% w/v SDS at 65°C for 5 to 6 times until the
background signal was low.
In situ RNA hybridization
ISH was carried out using paraffin sections (5 m) of embry-
onic, postnatal and adult brains (E11.5, E13.5, E15.5, E17.5,
P1.5 and P150) and a related [35S]UTP-labeled complemen-
tary RNA probe (Additional data file 8) as described previ-
ously (Section G in Additional data file 1) [123].
Screening of Sox4 and Sox11 sense and antisense 
transcript expression in the adult mouse brain, organs 
and both the proliferating and differentiating P19 cells 
and neurospheres
Strand-specific RT-qPCR
Total RNA was extracted from harvested organs using the
TRIzol®'s reagent (Invitrogen, Mulgrave, Victoria, Australia)
according to the manufacturer's protocol. To avoid genomic
DNA contamination, all isolated total RNA was treated with
the recombinant DNAse I enzyme provided by the DNA-
free™ kit (Applied Biosystems, Scoresby, Victoria, Australia)
according to the manufacturer's protocol. First strand cDNA
synthesis was carried out using strand-specific primers fol-
lowed by qPCR analysis as described above.
Embryonic neural stem cells grown as neurospheres
Mouse used for generation of neurospheres had a mixed
genetic background including MF1, 129SvEv, C57BL/6 and
CBA. Cerebral cortices from E14 embryos were dissected out
into calcium-magnesium-free phosphate-buffered saline. The
tissue was mechanically dissociated and centrifuged. The
cells were plated in complete neuroculture medium (Section
G in Additional data file 1) for 4 days followed by induction of
neuronal differentiation. These cells were then plated on
poly-D-lysine (catalogue number P6407, Sigma Aldrich, Cas-
tle Hill, New South Wales, Australia) and laminin (catalogue
number 23017-015, Invitrogen, Mulgrave, Victoria, Aus-
tralia) coated culture dishes in neuroculture medium with the
presence of 2% (v/v) fetal bovine serum but not epidermal
growth factor and basic fibroblast growth factor. The differ-
entiation was allowed to proceed for 5 days. Total RNA was
extracted from both proliferating and differentiating cells
using TRIzol® reagent as described above.
P19 embryonal carcinoma cells
P19 mouse embryonal carcinoma cells were cultured and dif-
ferentiated into neurons as described previously [124].http://genomebiology.com/2009/10/10/R104 Genome Biology 2009,     Volume 10, Issue 10, Article R104       Ling et al. R104.28
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Briefly, P19 cell cultures were maintained in P19GM complete
medium (Section G in Additional data file 1). For induction of
neuronal differentiation, 1 × 106 P19 cells were cultured in
suspension form using bacteriological Petri dishes. The
P19GM medium with additional supplementation of 5 × 10-
7M all-trans retinoic acid (catalogue number R-2625; Sigma
Aldrich, Castle Hill, New South Wales, Australia) was used for
the induction. After 4 days, P19 cells formed embryoid body
stages. Embryoid bodies were collected from suspension cul-
tures and re-plated in adherent culture flasks in the P19GM
medium with only 5% (v/v) fetal bovine serum and without
retinoic acid supplementation. The cells were allowed to dif-
ferentiate for 5 days. Total RNA was extracted from both pro-
liferating and differentiating cells using TRIzol® reagent as
described in above.
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